⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2555205 | 1.00 | — | — | |
| SCHEMBL19551977 | 1.00 | — | — | |
| SCHEMBL9504876 | 0.79 | — | — | |
| SCHEMBL1882577 | 0.79 | — | — | |
| SCHEMBL10525928 | 0.77 | TDP1 (0.50) | — | |
| SCHEMBL11335273 | 0.77 | TSHR (0.34) | — | |
| SCHEMBL6379379 | 0.76 | CTSK (0.39) | — | |
| SCHEMBL9736110 | 0.74 | TSHR (0.36) | — | |
| SCHEMBL10403653 | 0.74 | TSHR (0.36) | — | |
| SCHEMBL11105602 | 0.72 | TSHR (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2906566-A1 | PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2015-08-19 | — | — | EP | claimed |
| WO-2014056955-A1 | PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-04-17 | — | — | WO | claimed |
| EP-3728217-A1 | CHROMENOPYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS | Ravenna Pharmaceuticals, Inc. (US) | 2020-10-28 | — | — | EP | disclosed |
| EP-3700897-A1 | SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF | Bayer Pharma Aktiengesellschaft (DE) | 2020-09-02 | — | — | EP | disclosed |
| EP-3452472-A1 | HYDROXYALKYL-SUBSTITUTED HETEROARYLTRIAZOLE DERIVATIVES AND USES THEREOF | Bayer Aktiengesellschaft (DE) | 2019-03-13 | — | — | EP | disclosed |
| WO-2017191114-A1 | HYDROXYALKYL-SUBSTITUTED HETEROARYLTRIAZOLE DERIVATIVES AND USES THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2017-11-09 | — | — | WO | disclosed |
| WO-2017191117-A1 | V1A RECEPTOR ANTAGONISTS FOR USE IN THE TREATMENT OF RENAL DISEASES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-11-09 | — | — | WO | disclosed |
| EP-3071036-A1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | Dow AgroSciences LLC (US) | 2016-09-28 | — | — | EP | disclosed |
| WO-2015061165-A1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | DOW AGROSCIENCES LLC (US) | 2015-04-30 | — | — | WO | disclosed |
| EP-2710000-A1 | PARASITICIDAL DIHYDROISOXAZOLE COMPOUNDS | Eli Lilly and Company (US) | 2014-03-26 | — | — | EP | disclosed |
| EP-2558450-A1 | TRIAZOLE COMPOUNDS AS KSP INHIBITORS | Novartis AG (CH) | 2013-02-20 | — | — | EP | disclosed |
| WO-2012155676-A1 | PARASITICIDAL COMPOUNDS, METHODS, AND FORMULATIONS | ELI LILLY AND COMPANY (US) | 2012-11-22 | — | — | WO | disclosed |
| WO-2012158396-A1 | PARASITICIDAL DIHYDROISOXAZOLE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2012-11-22 | — | — | WO | disclosed |
| WO-2011128381-A1 | TRIAZOLE COMPOUNDS AS KSP INHIBITORS | NOVARTIS AG (CH) | 2011-10-20 | — | — | WO | disclosed |